Invention Grant
- Patent Title: Methods for determining DPP3 and therapeutic methods
-
Application No.: US16919449Application Date: 2020-07-02
-
Publication No.: US11726094B2Publication Date: 2023-08-15
- Inventor: Andreas Bergmann
- Applicant: 4TEEN4 PHARMACEUTICALS GMBH
- Applicant Address: DE Hennigsdorf
- Assignee: 4TEEN4 PHARMACEUTICALS GMBH
- Current Assignee: 4TEEN4 PHARMACEUTICALS GMBH
- Current Assignee Address: DE Hennigsdorf
- Agency: Millen, White, Zelano & Branigan, PC
- Agent Ryan Pool
- Priority: EP 166476 2016.04.21
- The original application number of the division: US16095563
- Main IPC: G01N33/58
- IPC: G01N33/58 ; G01N33/574 ; G01N33/68 ; C07K16/40 ; G01N33/543 ; A61K39/00
Abstract:
The present invention is directed to methods for determining active DPP3 in a bodily fluid sample, an assay or kit for determining active DPP3 in a bodily fluid sample, a method for diagnosing a disease or condition in a subject accompanied by or related to necrotic processes and methods of treating or preventing said disease.
Public/Granted literature
- US20200378977A1 METHODS FOR DETERMINING DPP3 AND THERAPEUTIC METHODS Public/Granted day:2020-12-03
Information query
IPC分类:
